2.Caspofungin and voriconazole combination therapy for invasive pulmonary aspergillosis in patients with liver failure: a report of two cases.
Chinese Journal of Hepatology 2014;22(3):239-240
Drug Therapy, Combination
;
Echinocandins
;
administration & dosage
;
therapeutic use
;
Humans
;
Invasive Pulmonary Aspergillosis
;
complications
;
drug therapy
;
Lipopeptides
;
Liver Failure
;
complications
;
drug therapy
;
microbiology
;
Male
;
Middle Aged
;
Voriconazole
;
administration & dosage
;
therapeutic use
3.A Case of Pseudomembranous Colitis after Voriconazole Therapy.
Jae Cheol KWON ; Min Kyu KANG ; Si Hyun KIM ; Su Mi CHOI ; Hee Je KIM ; Woo Sung MIN ; Dong Gun LEE
Yonsei Medical Journal 2011;52(5):863-865
This is a case report on a 35-year-old man with acute myelogenous leukemia who presented fever and intermittent mucoid loose stool to the emergency center. He had been taking voriconazole for invasive pulmonary aspergillosis. The flexible sigmoidoscopy was consistent with the diagnosis of pseudomembranous colitis.
Adult
;
Antifungal Agents/*adverse effects
;
Enterocolitis, Pseudomembranous/*chemically induced/pathology
;
Humans
;
Invasive Pulmonary Aspergillosis/complications/drug therapy
;
Leukemia, Myeloid, Acute/complications
;
Male
;
Opportunistic Infections/complications/drug therapy
;
Pyrimidines/*adverse effects
;
Triazoles/*adverse effects